Recent Quarter Total Invested
$150.03 M
Recent Quarter Institutional Ownership Percentage
63.63%
Total Invested of Last Quarter
$256.09 M
Ownership Percentage of Last Quarter
71.37%
Adaptimmune Therapeutics plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MATRIX CAPITAL MANAGEMENT COMPANY, LP | 08/14/2024 | 38.97 M | $38.00 M | 0.00% | 16.11% |
| ECOR1 CAPITAL, LLC | 08/14/2024 | 27.40 M | $26.72 M | 0.00% | 11.33% |
| NEA MANAGEMENT COMPANY, LLC | 08/14/2024 | 17.08 M | $16.65 M | 0.00% | 7.06% |
| BAILLIE GIFFORD & CO | 07/25/2024 | 15.15 M | $14.77 M | -4.55% | 6.26% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 08/14/2024 | 12.35 M | $12.04 M | 15.56% | 5.10% |
| PFM HEALTH SCIENCES, LP | 08/14/2024 | 10.52 M | $10.26 M | 0.93% | 4.35% |
| MPM ASSET MANAGEMENT LLC | 08/14/2024 | 5.56 M | $5.42 M | 0.00% | 2.30% |
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 5.10 M | $4.97 M | 0.00% | 2.11% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 4.65 M | $4.53 M | -0.31% | 1.92% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 2.43 M | $2.36 M | 0.00% | 1.00% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 2.34 M | $2.28 M | -78.27% | 0.97% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 1.79 M | $1.74 M | 28.35% | 0.74% |
| TANG CAPITAL MANAGEMENT LLC | 08/14/2024 | 1.74 M | $1.70 M | 20.78% | 0.72% |
| FMR LLC | 08/13/2024 | 1.69 M | $1.65 M | -2.43% | 0.70% |
| JPMORGAN CHASE & CO | 08/12/2024 | 1.04 M | $1.01 M | 13.36% | 0.43% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 779,615 | $760,047 | -5.52% | 0.32% |
| REDMILE GROUP, LLC | 08/14/2024 | 715,607 | $697,645 | 0.00% | 0.30% |
| ACUITAS INVESTMENTS, LLC | 08/05/2024 | 541,201 | $527,617 | 0.54% | 0.22% |
| MORGAN STANLEY | 08/14/2024 | 440,832 | $429,768 | 18.10% | 0.18% |
| RATHBONES GROUP PLC | 08/09/2024 | 432,818 | $421,954 | 0.00% | 0.18% |
| STATE STREET CORP | 08/14/2024 | 390,901 | $381,089 | 25.07% | 0.16% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2024 | 341,064 | $332,503 | 0.00% | 0.14% |
| KEY CLIENT FIDUCIARY ADVISORS, LLC | 07/16/2024 | 263,989 | $257,363 | -1.74% | 0.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 242,144 | $236,066 | 329.81% | 0.10% |
| LPL FINANCIAL LLC | 08/07/2024 | 198,856 | $193,865 | 82.68% | 0.08% |
| BLACKROCK INC. | 08/13/2024 | 193,757 | $188,894 | -33.12% | 0.08% |
| MARSHALL WACE, LLP | 08/14/2024 | 144,880 | $140,534 | -42.96% | 0.06% |
| CITADEL ADVISORS LLC | 08/14/2024 | 142,891 | $139,304 | -41.36% | 0.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 117,909 | $114,949 | 0.00% | 0.05% |
| MARQUETTE ASSET MANAGEMENT, LLC | 08/14/2024 | 98,589 | $96,115 | 0.00% | 0.04% |
| CAPTRUST FINANCIAL ADVISORS | 08/15/2024 | 83,041 | $80,957 | -25.82% | 0.03% |
| VIRTU FINANCIAL LLC | 08/09/2024 | 79,239 | $77,000 | 100.00% | 0.03% |
| JANE STREET GROUP, LLC | 08/15/2024 | 75,576 | $73,679 | 100.00% | 0.03% |
| CITADEL ADVISORS LLC | 08/14/2024 | 66,800 | $65,123 | 56.07% | 0.03% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 63,672 | $62,074 | 17.54% | 0.03% |
| NORTHERN TRUST CORP | 08/14/2024 | 51,861 | $50,559 | -9.81% | 0.02% |
| BARCLAYS PLC | 08/14/2024 | 50,061 | $49,000 | 0.00% | 0.02% |
| OPPENHEIMER & CO INC | 08/08/2024 | 39,298 | $38,312 | -10.34% | 0.02% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 07/16/2024 | 35,102 | $34,221 | 8.88% | 0.01% |
| INVESCO LTD. | 08/13/2024 | 34,743 | $33,871 | 100.00% | 0.01% |
| GROUP ONE TRADING, L.P. | 08/14/2024 | 34,037 | $33,183 | 52.18% | 0.01% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 33,337 | $32,500 | -27.74% | 0.01% |
| MAIN STREET FINANCIAL SOLUTIONS, LLC | 08/08/2024 | 31,190 | $30,407 | 0.00% | 0.01% |
| CSS LLC/IL | 08/14/2024 | 30,702 | $29,931 | 0.00% | 0.01% |
| DLK INVESTMENT MANAGEMENT, LLC | 08/05/2024 | 30,512 | $29,746 | 0.00% | 0.01% |
| SIMON QUICK ADVISORS, LLC | 08/02/2024 | 30,000 | $29,247 | 0.00% | 0.01% |
| JANNEY MONTGOMERY SCOTT LLC | 07/25/2024 | 30,000 | $29,000 | 0.00% | 0.01% |
| COLUMBIA ADVISORY PARTNERS LLC | 07/12/2024 | 28,087 | $27,382 | 80.22% | 0.01% |
| STIFEL FINANCIAL CORP | 08/13/2024 | 27,619 | $26,927 | 16.06% | 0.01% |
| PROSPERITY WEALTH MANAGEMENT, INC. | 08/14/2024 | 26,620 | $25,952 | 0.00% | 0.01% |
Adaptimmune Therapeutics plcinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ADAP shares?
During the previous two years, 103 institutional investors and hedge funds held shares of Adaptimmune Therapeutics plc. The most heavily invested institutionals were:
Matrix Capital Management Company, LP: 38.97 M
EcoR1 Capital, LLC: 27.4 M
NEA Management Company, LLC: 17.08 M
BAILLIE GIFFORD & CO: 15.15 M
Long Focus Capital Management, LLC: 12.35 M
PFM Health Sciences, LP: 10.52 M
-
What percentage of Adaptimmune Therapeutics plc stock is owned by institutional investors?
63.63% of Adaptimmune Therapeutics plc stock is owned by institutional investors.
-
How much institutional buying is happening at ADAP ?
Institutional investors have bought a total of 154.36 M shares in the last 24 months. This purchase volume represents approximately $146.64 M in transactions.